Description
GE Healthcare’s most advanced SPECT/CT was made to help fulfill the promise of nuclear medicine’s Theranostics revolution.
Optimizing the highly-targeted, personalized oncological care now made possible by Theranostics (therapeutics & diagnostics) requires accurate quantitation. This is what drove the creation of StarGuide. StarGuide attains resolution and sensitivity levels so critical in monitoring doses from therapy. Its next-generation CZT detectors are capable of imaging the dual energy peaks of 177Lu essential to Theranostics.
Please click HERE for more details on the manufacturer’s official website.
G-MedTech Reviews –
The StarGuide has the ability to determine myocardial blood flow reserve in patients who do not have a severe epicardial coronary artery stenosis on angiography but have continued angina as a result of microvascular dysfunction, essentially the tiny vessels that are not amenable to stents but can limit blood flow. One of the more noticeable improvements is using the technology to evaluate patients for endocarditis, an infection of the heart’s inner lining. The transition to the new GE HealthCare technology also provided a way for physicians to team up and learn in tandem with the Nuclear Technologists—something very beneficial to patients as our thought processes on image quality and acquisition are better aligned.
John Hatanelas, DO, OhioHealth noninvasive cardiologist
G-MedTech –
It’s very impressive. StarGuide allows us to acquire patient data in the best conditions… The detectors are always as close as possible to the patient, which really improves spatial resolution and sensitivity…The most improved performance is the energy resolution. This is very impressive and it can help us to do dual isotope acquisition very easily.
Gilles Le Rouzic
Medical physicist, Hospital of Orleans, France (2+ years working with StarGuide)